Abstract
<div>Abstract<p><b>Purpose:</b> The combined use of microarray technologies and bioinformatics analysis has improved our understanding of biological complexity of multiple myeloma (MM). In contrast, the application of the same technology in the attempt to predict clinical outcome has been less successful with the identification of heterogeneous molecular signatures. Herein, we have reconstructed gene regulatory networks in a panel of 1,883 samples from MM patients derived from publicly available gene expression sets, to allow the identification of robust and reproducible signatures associated with poor prognosis across independent data sets.</p><p><b>Experimental Design:</b> Gene regulatory networks were reconstructed by using Algorithm for the Reconstruction of Accurate Cellular Networks (ARACNe) and microarray data from seven MM data sets. Critical analysis of network components was applied to identify genes playing an essential role in transcriptional networks, which are conserved between data sets.</p><p><b>Results:</b> Network critical analysis revealed that (i) <i>CCND1</i> and <i>CCND2</i> were the most critical genes; (ii) <i>CCND2</i>, <i>AIF1</i>, and <i>BLNK</i> had the largest number of connections shared among the data sets; (iii) robust gene signatures with prognostic power were derived from the most critical transcripts and from shared primary neighbors of the most connected nodes. Specifically, a critical-gene model, comprising <i>FAM53B</i>, <i>KIF21B</i>, <i>WHSC1</i>, and <i>TMPO</i>, and a neighbor-gene model, comprising <i>BLNK</i> shared neighbors <i>CSGALNACT1</i> and <i>SLC7A7</i>, predicted survival in all data sets with follow-up information.</p><p><b>Conclusions:</b> The reconstruction of gene regulatory networks in a large panel of MM tumors defined robust and reproducible signatures with prognostic importance, and may lead to identify novel molecular mechanisms central to MM biology. <i>Clin Cancer Res; 17(23); 7402–12. ©2011 AACR</i>.</p></div>
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
